For over 20 years, bioStrategies has developed commercial insight to inform evidence-based impactful commercialization strategies for pharmaceuticals, vaccines, medical devices, and diagnostics. Our approach combines detailed market research and proprietary analytical tools with technical and strategic understanding to deliver timely, actionable recommendations. We specialize in evaluation of complex commercialization issues in the U.S. and Europe as well as other global healthcare markets